Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors

Immune checkpoint inhibitors (ICIs) have completely changed the treatment of cancer, and they also can cause multiple organ immune-related adverse reactions (irAEs). Among them, rheumatic irAE is less common, mainly including inflammatory arthritis, rheumatic myalgia/giant cell arteritis, inflammato...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yan, Zeng, Lin, Shen, Qinglin, Zhou, Zhiyong, Mao, Zhifang, Wang, Qin, Zhang, Xiquan, Li, Yingliang, Yao, Weirong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424376/
https://www.ncbi.nlm.nih.gov/pubmed/32832568
http://dx.doi.org/10.1155/2020/2640273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424376/
https://www.ncbi.nlm.nih.gov/pubmed/32832568
http://dx.doi.org/10.1155/2020/2640273

Ejemplares similares